1. A Genetic Variation of SOD2 Does Not Determine Duration of Response to Androgen Deprivation Therapy for Prostate Cancer. Issue 14 (21st June 2016) Authors: Xie, Wanling; Drouin, Sarah; Nakabayashi, Mari; Pomerantz, Mark; Lee, Gwo‐Shu Mary; Kantoff, Philip W.; Sharifi, Nima Journal: Prostate Issue: Volume 76:Issue 14(2016) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma. (August 2020) Authors: McGregor, Bradley A.; Lalani, Aly-Khan A.; Xie, Wanling; Steinharter, John A.; E. Bakouny, Ziad; Martini, Dylan J.; Fleischer, Justin H.; Abou-Alaiwi, Sarah; Nassar, Amin; Nuzzo, Pier V.; Kaymakcalan, Marina D.; Braun, David A.; Wei, Xiao X.; Harshman, Lauren C.; Bilen, Mehmet A.; Choueiri, Toni K. Journal: European journal of cancer Issue: Volume 135(2020) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of genetic variation of the six gene prognostic model for castration‐resistant prostate cancer with survival. Issue 1 (23rd August 2018) Authors: Xie, Wanling; Stopsack, Konrad H.; Drouin, Sarah J.; Fu, Henry; Pomerantz, Mark M.; Mucci, Lorelei A.; Lee, Gwo‐Shu M.; Kantoff, Philip W. Journal: Prostate Issue: Volume 79:Issue 1(2019) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis. Issue 7 (5th February 2016) Authors: Xie, Wanling; Yang, Ming; Chan, June; Sun, Tong; Mucci, Lorelei A.; Penney, Kathryn L.; Lee, Gwo‐Shu Mary; Kantoff, Philip W. Journal: Prostate Issue: Volume 76:Issue 7(2016) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. (16th February 2022) Authors: McGregor, Bradley A.; Xie, Wanling; Adib, Elio; Stadler, Walter M.; Zakharia, Yousef; Alva, Aijai; Michaelson, M. Dror; Gupta, Shilpa; Lam, Elaine T.; Farah, Subrina; Nassar, Amin H.; Wei, Xiao X.; Kilbridge, Kerry L.; Harshman, Lauren; Signoretti, Sabina; Sholl, Lynette; Kwiatkowski, David J.; M... Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Issue 4 (April 2019) Authors: Martínez Chanzá, Nieves; Xie, Wanling; Asim Bilen, Mehmet; Dzimitrowicz, Hannah; Burkart, Jarred; Geynisman, Daniel M; Balakrishnan, Archana; Bowman, I Alex; Jain, Rohit; Stadler, Walter; Zakharia, Yousef; Narayan, Vivek; Beuselinck, Benoit; McKay, Rana R; Tripathi, Abhishek; Pachynski, Russell; ... Journal: Lancet oncology Issue: Volume 20:Issue 4(2019) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. Issue 1 (22nd January 2018) Authors: Lalani, Aly-Khan A.; Xie, Wanling; Martini, Dylan J.; Steinharter, John A.; Norton, Craig K.; Krajewski, Katherine M.; Duquette, Audrey; Bossé, Dominick; Bellmunt, Joaquim; Van Allen, Eliezer M.; McGregor, Bradley A.; Creighton, Chad J.; Harshman, Lauren C.; Choueiri, Toni K. Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinations. (June 2015) Authors: Varga, Cindy; Xie, Wanling; Laubach, Jacob; Ghobrial, Irene M.; O'Donnell, Elizabeth K.; Weinstock, Matthew; Paba‐Prada, Claudia; Warren, Diane; Maglio, Michelle E.; Schlossman, Robert; Munshi, Nikhil C.; Raje, Noopur; Weller, Edie; Anderson, Kenneth C.; Mitsiades, Constantine S.; Richardson, Pau... Journal: British journal of haematology Issue: Volume 169:Number 6(2015:Jun.) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma. Issue 17 (November 2015) Authors: Albiges, Laurence; Fay, André P.; Xie, Wanling; Krajewski, Katherine; McDermott, David F.; Heng, Daniel Y.C.; Dariane, Charles; DeVelasco, Guillermo; Lester, Renee; Escudier, Bernard; Choueiri, Toni K. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of disease‐free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial‐level meta‐analysis. Issue 5 (19th December 2017) Authors: Harshman, Lauren C.; Xie, Wanling; Moreira, Raphael B.; Bossé, Dominick; Ruiz Ares, Gustavo J.; Sweeney, Christopher J.; Choueiri, Toni K. Journal: Cancer Issue: Volume 124:Issue 5(2018) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗